The institution

Professor-led scrutiny before treatment begins.

A consequential aesthetic decision cannot be reduced to selecting a procedure or identifying a visible clinician. Sound judgement requires the objective, indication, alternatives, delivery system, risks and long-term consequences to be considered together.

Transparency RegisterTR 01 TR 07

Information asymmetry

More information can still leave the central question unanswered.

The person making the decision rarely has access to the same information as the people proposing or delivering treatment.

Credentials may be difficult to compare. Photographs are selective. Procedure names conceal differences in technique. A recognised product does not establish an appropriate indication, and prominence does not by itself prove suitability for a particular anatomy or revision problem.

Professor-led review makes those uncertainties visible, tests what can be verified and identifies what must be resolved before any commitment is made.

Transparency RegisterTR 07 TR 04

Three disciplines

One decision framework.

Each discipline answers a different question. Together they prevent a treatment decision from being mistaken for a product choice.

01
Decision strategy begins with the individual objective and examines feasibility, proportion, timing, biological limits and the interaction of interventions over time.
02
Due diligence asks whether the proposed treatment system can credibly support the intended objective—from clinical experience to facility, anaesthesia, product traceability, follow-up, emergency response and revision capability.
03
The risk framework distinguishes unavoidable clinical uncertainty from preventable exposure and brings clinical, aesthetic, operational, logistical and continuity risks into one decision framework.

Transparency RegisterTR 04 TR 01

The whole pathway

Assessment begins with the decision at hand—not a clinic’s menu.

A mandate may begin before a clinician has been selected or after a proposal, operation, complication or disappointing result. Scope is defined around the question and never silently expanded.

01
Objective and indication
02
Treatment alternatives and sequence
03
Independent second review
04
Clinician and facility assessment
05
Operating and anaesthesia environment
06
Product or implant considerations
07
Follow-up and international handover
08
Complication and revision strategy
09
Long-term continuity

Transparency RegisterTR 01 TR 07

Long-term strategy

Aesthetic decisions continue after the procedure ends.

Tissue change, ageing, prior interventions, healing and revision options shape what remains possible. Strategy should preserve coherence over time.

Transparency RegisterTR 07 TR 04

Structural independence

The appointed professors answer only to independent judgement.

Every specialist is engaged for a defined review question. Treatment, practitioner selection and clinical care remain institutionally separate from that assessment.

Institutional standard

Defined roles · case-specific conflict review · documented information boundaries

Conflict review

Relevant relationships are examined before assignment.

Professional, clinical, scientific, manufacturer-linked or other relationships that could affect the review question are examined in advance and documented for the mandate.

Assessment logic

Prominence and familiarity do not replace evidence.

The assessment is based on indication, verifiable competence, team quality, infrastructure, risk control, revision capability and long-term strategy. Participating professors and specialists do not provide clinical treatment within the mandate.

Transparency RegisterTR 02

CONTROLLED ACCESS

Access requires verified authority.

The protected knowledge and review environment is reserved for family offices, qualified agencies, authorised professional representatives and private principals approved through the exceptional direct-access route.

Begin the preliminary access review Review Process